WallStreetZenWallStreetZen

NASDAQ: ALKS
Alkermes PLC Earnings & Revenue

ALKS past revenue growth

How has ALKS's revenue growth performed historically?
Company
49.61%
Industry
9.75%
Market
17.79%
ALKS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALKS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ALKS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ALKS earnings and revenue history

Current Revenue
$1.7B
Current Earnings
$355.8M
Current Profit Margin
21.4%
ALKS's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ALKS Return on Equity

Current Company
29.4%
Current Industry
21.9%
Current Market
188%
ALKS's Return on Equity (29.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALKS announces earnings.

ALKS Return on Assets

Current Company
16.7%
Current Industry
6.1%
ALKS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALKS Return on Capital Employed

Current Company
17.4%
Current Industry
8.2%
ALKS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALKS vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALKS$1.66B$356.08M$355.76M+8.74%N/A
LNTH$1.30B$491.01M$326.66M+30.44%+35.21%
PRGO$4.65B$559.90M-$4.10M-0.70%N/A
ALVO$63.75M-$436.20M-$595.68M+367.33%N/A
PBH$1.13B$16.86M-$80.67M+2.74%N/A

ALKS earnings dates

Next earnings date
Apr 24, 2024

Alkermes Earnings & Revenue FAQ

What were ALKS's earnings last quarter?

On Invalid Date, Alkermes (NASDAQ: ALKS) reported Q4 2023 earnings per share (EPS) of $0.68, up 477.78% year over year. Total Alkermes earnings for the quarter were $112.78 million. In the same quarter last year, Alkermes's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Alkermes stock.

What was ALKS's earnings growth in the past year?

As of Q1 2024, Alkermes's earnings has grown year over year. Alkermes's earnings in the past year totalled $355.76 million.

What is ALKS's earnings date?

Alkermes's earnings date is Invalid Date. Add ALKS to your watchlist to be reminded of ALKS's next earnings announcement.

What was ALKS's revenue last quarter?

On Invalid Date, Alkermes (NASDAQ: ALKS) reported Q4 2023 revenue of $377.48 million up 23.89% year over year. In the same quarter last year, Alkermes's revenue was $304.67 million.

What was ALKS's revenue growth in the past year?

As of Q1 2024, Alkermes's revenue has grown 49.61% year over year. This is 39.86 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.75%. Alkermes's revenue in the past year totalled $1.66 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.